Innovative Nano-Biosensor Developed for Rapid Detection of Viruses
|
By LabMedica International staff writers Posted on 23 Mar 2016 |

Image: A novel nano-biosensor has been developed for lower-cost, rapid virus detection based on upconversion luminescence resonance energy transfer (LRET) technology and DNA oligo hybridization. Testing takes only 2–3 hours, about 10x faster traditional clinical methods (Photo courtesy of the Hong Kong Polytechnic University).
Scientists have invented a compact, easy-to-use biosensor for rapid, sensitive detection of flu and other viruses by utilizing the optical method of upconversion luminescence resonance energy transfer (LRET).
The new method, invented by researchers at the Hong Kong Polytechnic University (PolyU; Hong Kong), involves simple operational procedures that significantly reduce testing time from around 1–3 days to 2–3 hours, making it over 10 times quicker than traditional clinical methods. Furthermore, it is a low-cost test—about 80% lower than traditional tests, and the technology can be widely used to detect different types of viruses
RT-PCR is expensive and time-consuming while the sensitivity for ELISA is relatively low. Such limitations make these methods difficult for use in front-line and on-site virus detection. This challenge paved the way for the researchers to develop a new biosensor based on the luminescent technique.
The luminescent technique operates analogous to two matching pieces of magnet with attraction force. It involves the development of upconversion nanoparticles (UCNPs) conjugated with an oligo probe whose DNA base pairs are complementary with that of the gold nanoparticles (AuNPs) flu virus oligo. Given the complementarity, the two oligos undergo DNA-DNA hybridization. Upon being illuminated by a portable near-infrared laser pen, the UCNPs emit eye-visible green light while the AuNPs would absorb the green light. One can easily quantify the concentration of the targeted flu virus by measuring the decrease in green light intensity.
Initially, the researchers used upconversion LRET for ultrasensitive virus detection in liquid-phase system. The team then further improved the sensitivity by using a solid-phased nanoporous membrane system (NAAO). As NAAO membrane consists of many hollow channels, it allows more space for oligo hybridization to take place, increasing sensitivity by over 10 folds compared to the liquid-phase system, based on detection using inactivated virus samples.
The new biosensor does not require expensive instruments and sophisticated operational skills, and has sensitivity comparable to traditional clinical methods. In comparison to conventional downconversion luminescent technique, it causes low damage to genetic materials and does not induce background fluorescence. In addition, a complementary probe can be designed to target detection of any virus with known genetic sequence. In other words, the new method can be widely used for the detection of different types of viruses simply by modifying the UCNPs capture probe.
The team will continue to enhance the biosensor for virus detection, including increasing sensitivity and specificity, and developing a matrix for multiplex detection of multiple flu viruses on a single testing platform.
The related results have been recently published in the two nanomaterial research journals ACS Nano and Small.
Related Links:
The Hong Kong Polytechnic University
The new method, invented by researchers at the Hong Kong Polytechnic University (PolyU; Hong Kong), involves simple operational procedures that significantly reduce testing time from around 1–3 days to 2–3 hours, making it over 10 times quicker than traditional clinical methods. Furthermore, it is a low-cost test—about 80% lower than traditional tests, and the technology can be widely used to detect different types of viruses
RT-PCR is expensive and time-consuming while the sensitivity for ELISA is relatively low. Such limitations make these methods difficult for use in front-line and on-site virus detection. This challenge paved the way for the researchers to develop a new biosensor based on the luminescent technique.
The luminescent technique operates analogous to two matching pieces of magnet with attraction force. It involves the development of upconversion nanoparticles (UCNPs) conjugated with an oligo probe whose DNA base pairs are complementary with that of the gold nanoparticles (AuNPs) flu virus oligo. Given the complementarity, the two oligos undergo DNA-DNA hybridization. Upon being illuminated by a portable near-infrared laser pen, the UCNPs emit eye-visible green light while the AuNPs would absorb the green light. One can easily quantify the concentration of the targeted flu virus by measuring the decrease in green light intensity.
Initially, the researchers used upconversion LRET for ultrasensitive virus detection in liquid-phase system. The team then further improved the sensitivity by using a solid-phased nanoporous membrane system (NAAO). As NAAO membrane consists of many hollow channels, it allows more space for oligo hybridization to take place, increasing sensitivity by over 10 folds compared to the liquid-phase system, based on detection using inactivated virus samples.
The new biosensor does not require expensive instruments and sophisticated operational skills, and has sensitivity comparable to traditional clinical methods. In comparison to conventional downconversion luminescent technique, it causes low damage to genetic materials and does not induce background fluorescence. In addition, a complementary probe can be designed to target detection of any virus with known genetic sequence. In other words, the new method can be widely used for the detection of different types of viruses simply by modifying the UCNPs capture probe.
The team will continue to enhance the biosensor for virus detection, including increasing sensitivity and specificity, and developing a matrix for multiplex detection of multiple flu viruses on a single testing platform.
The related results have been recently published in the two nanomaterial research journals ACS Nano and Small.
Related Links:
The Hong Kong Polytechnic University
Latest Technology News
- AI-Generated Sensors Open New Paths for Early Cancer Detection
- Pioneering Blood Test Detects Lung Cancer Using Infrared Imaging
- AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
- Diagnostic Chip Monitors Chemotherapy Effectiveness for Brain Cancer
- Machine Learning Models Diagnose ALS Earlier Through Blood Biomarkers
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
- AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
- AI-Powered Biosensor Technology to Enable Breath Test for Lung Cancer Detection
- AI Model Achieves Breakthrough Accuracy in Ovarian Cancer Detection
- Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
- Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement

- Embedded GPU Platform Enables Rapid Blood Profiling for POC Diagnostics
Channels
Clinical Chemistry
view channel
Blood Test Could Predict and Identify Early Relapses in Myeloma Patients
Multiple myeloma is an incurable cancer of the bone marrow, and while many patients now live for more than a decade after diagnosis, a significant proportion relapse much earlier with poor outcomes.... Read more
Compact Raman Imaging System Detects Subtle Tumor Signals
Accurate cancer diagnosis often depends on labor-intensive tissue staining and expert pathological review, which can delay results and limit access to rapid screening. These conventional methods also make... Read moreMolecular Diagnostics
view channel
Genetic Testing Identifies CHIP Patients at Increased Heart Disease Risk After Cancer Treatment
Genetic testing in cancer care often reveals unexpected findings that are not directly related to the tumor itself. One such finding is clonal hematopoiesis of indeterminate potential, a condition caused... Read more
Advances in Liquid Biopsies Improve Detection of Lung Cancer Mutations
Lung cancer remains one of the deadliest cancers, largely because diagnosis often occurs at an advanced stage when treatment options are limited. In non-small cell lung cancer (NSCLC), identifying genetic... Read moreHematology
view channel
MRD Tests Could Predict Survival in Leukemia Patients
Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Blood Test Could Identify Colon Cancer Patients to Benefit from NSAIDs
Colon cancer remains a major cause of cancer-related illness, with many patients facing relapse even after surgery and chemotherapy. Up to 40% of people with stage III disease experience recurrence, highlighting... Read morePathology
view channel
AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery
Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Deep Learning–Based Method Improves Cancer Diagnosis
Identifying vascular invasion is critical for determining how aggressive a cancer is, yet doing so reliably can be difficult using standard pathology workflows. Conventional methods require multiple chemical... Read more
ADLM Updates Expert Guidance on Urine Drug Testing for Patients in Emergency Departments
Urine drug testing plays a critical role in the emergency department, particularly for patients presenting with suspected overdose or altered mental status. Accurate and timely results can directly influence... Read moreTechnology
view channel
AI-Generated Sensors Open New Paths for Early Cancer Detection
Cancers are far easier to treat when detected early, yet many tumors remain invisible until they are advanced or have recurred after surgery. Early-stage disease often produces signals that are too weak... Read more
Pioneering Blood Test Detects Lung Cancer Using Infrared Imaging
Detecting cancer early and tracking how it responds to treatment remains a major challenge, particularly when cancer cells are present in extremely low numbers in the bloodstream. Circulating tumor cells... Read moreIndustry
view channel
WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
World Health Expo (WHX) Labs in Dubai (formerly Medlab Middle East), which will be held at Dubai World Trade Centre from 10-13 February, will address the growing global threat of antimicrobial resistance... Read more







